Trends in Illness Severity and Length of Stay in Inner-city Adolescents Hospitalized for Pelvic Inflammatory Disease

Paritosh Kaul, Catherine Stevens-Simon, Arti Saproo, Susan M. Coupey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: In 1998, the Centers for Disease Control and Prevention (CDC) changed their guidelines for treatment of adolescents with pelvic inflammatory disease (PID), no longer recommending hospitalization of all teenagers. Study Objectives: (1) To determine the proportion of adolescents with PID who were admitted for failed outpatient treatment after the CDC guideline change. (2) To determine if adolescents admitted for PID after the guideline change needed longer hospital stays and/or were more likely to be "very ill" [as measured by inflammation markers, e.g. fever] or to have tubo-ovarian abscess (TOA) than those admitted before the change. Design: Retrospective chart review. Setting/Participants: All 12-21-year-old females with the diagnosis of PID admitted to an adolescent inpatient unit in an inner-city teaching hospital during a two-year period before [T1=1995-1997 (54 cases)] and after [T2=1998-2000 (91 cases)] the CDC guideline change. Interventions: None. Main Outcome measures: Reason for admission (failed outpatient treatment; TOA; or admission at the time of diagnosis of PID); clinical toxicity at admission, and length of hospital stay (LOS). Results: During T2, 22% of PID admissions were for failure of outpatient therapy. However, those admitted after failure of outpatient therapy (n=20) in T2 were less likely to be "very ill" than those who were admitted at the time of PID diagnosis in either T1 or T2 (n=123) [RR:0.30; 95% CI:0.09-0.94]. Mean LOS for females admitted to the adolescent unit with all diagnoses other than PID did not change between T1 and T2 but mean LOS for those diagnosed with PID decreased significantly from 6.3 ± 3.7 days to 4.7 ± 2.7 days, respectively (P = 0.002). LOS for PID was longer for younger (<16 years; 8.20 ± 4.5 days) than older (≥16 years; 5.0 ± 2.8 days) girls (P = 0.02) and for adolescents with TOA (7.9 ± 5.0 days) than for those without (5.3 ± 2.9 days) (P = 0.05). Conclusion: At our medical center, after the CDC guideline change many adolescents with PID were admitted because of failure of outpatient therapy but they were not sicker than those admitted at the time of diagnosis and overall LOS for PID was shorter. These findings are reassuring because they suggest that an initial trial of outpatient therapy for PID is unlikely to harm adolescents and may lead to significant cost savings.

Original languageEnglish (US)
Pages (from-to)289-293
Number of pages5
JournalJournal of Pediatric and Adolescent Gynecology
Volume21
Issue number5
DOIs
StatePublished - Oct 2008

Fingerprint

Hospitalized Adolescent
Pelvic Inflammatory Disease
Length of Stay
Outpatients
Centers for Disease Control and Prevention (U.S.)
Guidelines
Abscess
Therapeutics
Cost Savings
Urban Hospitals

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Trends in Illness Severity and Length of Stay in Inner-city Adolescents Hospitalized for Pelvic Inflammatory Disease. / Kaul, Paritosh; Stevens-Simon, Catherine; Saproo, Arti; Coupey, Susan M.

In: Journal of Pediatric and Adolescent Gynecology, Vol. 21, No. 5, 10.2008, p. 289-293.

Research output: Contribution to journalArticle

@article{caf07ae33f8c441ab7250339b2c9f1fd,
title = "Trends in Illness Severity and Length of Stay in Inner-city Adolescents Hospitalized for Pelvic Inflammatory Disease",
abstract = "Background: In 1998, the Centers for Disease Control and Prevention (CDC) changed their guidelines for treatment of adolescents with pelvic inflammatory disease (PID), no longer recommending hospitalization of all teenagers. Study Objectives: (1) To determine the proportion of adolescents with PID who were admitted for failed outpatient treatment after the CDC guideline change. (2) To determine if adolescents admitted for PID after the guideline change needed longer hospital stays and/or were more likely to be {"}very ill{"} [as measured by inflammation markers, e.g. fever] or to have tubo-ovarian abscess (TOA) than those admitted before the change. Design: Retrospective chart review. Setting/Participants: All 12-21-year-old females with the diagnosis of PID admitted to an adolescent inpatient unit in an inner-city teaching hospital during a two-year period before [T1=1995-1997 (54 cases)] and after [T2=1998-2000 (91 cases)] the CDC guideline change. Interventions: None. Main Outcome measures: Reason for admission (failed outpatient treatment; TOA; or admission at the time of diagnosis of PID); clinical toxicity at admission, and length of hospital stay (LOS). Results: During T2, 22{\%} of PID admissions were for failure of outpatient therapy. However, those admitted after failure of outpatient therapy (n=20) in T2 were less likely to be {"}very ill{"} than those who were admitted at the time of PID diagnosis in either T1 or T2 (n=123) [RR:0.30; 95{\%} CI:0.09-0.94]. Mean LOS for females admitted to the adolescent unit with all diagnoses other than PID did not change between T1 and T2 but mean LOS for those diagnosed with PID decreased significantly from 6.3 ± 3.7 days to 4.7 ± 2.7 days, respectively (P = 0.002). LOS for PID was longer for younger (<16 years; 8.20 ± 4.5 days) than older (≥16 years; 5.0 ± 2.8 days) girls (P = 0.02) and for adolescents with TOA (7.9 ± 5.0 days) than for those without (5.3 ± 2.9 days) (P = 0.05). Conclusion: At our medical center, after the CDC guideline change many adolescents with PID were admitted because of failure of outpatient therapy but they were not sicker than those admitted at the time of diagnosis and overall LOS for PID was shorter. These findings are reassuring because they suggest that an initial trial of outpatient therapy for PID is unlikely to harm adolescents and may lead to significant cost savings.",
author = "Paritosh Kaul and Catherine Stevens-Simon and Arti Saproo and Coupey, {Susan M.}",
year = "2008",
month = "10",
doi = "10.1016/j.jpag.2008.07.014",
language = "English (US)",
volume = "21",
pages = "289--293",
journal = "Journal of Pediatric and Adolescent Gynecology",
issn = "1083-3188",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Trends in Illness Severity and Length of Stay in Inner-city Adolescents Hospitalized for Pelvic Inflammatory Disease

AU - Kaul, Paritosh

AU - Stevens-Simon, Catherine

AU - Saproo, Arti

AU - Coupey, Susan M.

PY - 2008/10

Y1 - 2008/10

N2 - Background: In 1998, the Centers for Disease Control and Prevention (CDC) changed their guidelines for treatment of adolescents with pelvic inflammatory disease (PID), no longer recommending hospitalization of all teenagers. Study Objectives: (1) To determine the proportion of adolescents with PID who were admitted for failed outpatient treatment after the CDC guideline change. (2) To determine if adolescents admitted for PID after the guideline change needed longer hospital stays and/or were more likely to be "very ill" [as measured by inflammation markers, e.g. fever] or to have tubo-ovarian abscess (TOA) than those admitted before the change. Design: Retrospective chart review. Setting/Participants: All 12-21-year-old females with the diagnosis of PID admitted to an adolescent inpatient unit in an inner-city teaching hospital during a two-year period before [T1=1995-1997 (54 cases)] and after [T2=1998-2000 (91 cases)] the CDC guideline change. Interventions: None. Main Outcome measures: Reason for admission (failed outpatient treatment; TOA; or admission at the time of diagnosis of PID); clinical toxicity at admission, and length of hospital stay (LOS). Results: During T2, 22% of PID admissions were for failure of outpatient therapy. However, those admitted after failure of outpatient therapy (n=20) in T2 were less likely to be "very ill" than those who were admitted at the time of PID diagnosis in either T1 or T2 (n=123) [RR:0.30; 95% CI:0.09-0.94]. Mean LOS for females admitted to the adolescent unit with all diagnoses other than PID did not change between T1 and T2 but mean LOS for those diagnosed with PID decreased significantly from 6.3 ± 3.7 days to 4.7 ± 2.7 days, respectively (P = 0.002). LOS for PID was longer for younger (<16 years; 8.20 ± 4.5 days) than older (≥16 years; 5.0 ± 2.8 days) girls (P = 0.02) and for adolescents with TOA (7.9 ± 5.0 days) than for those without (5.3 ± 2.9 days) (P = 0.05). Conclusion: At our medical center, after the CDC guideline change many adolescents with PID were admitted because of failure of outpatient therapy but they were not sicker than those admitted at the time of diagnosis and overall LOS for PID was shorter. These findings are reassuring because they suggest that an initial trial of outpatient therapy for PID is unlikely to harm adolescents and may lead to significant cost savings.

AB - Background: In 1998, the Centers for Disease Control and Prevention (CDC) changed their guidelines for treatment of adolescents with pelvic inflammatory disease (PID), no longer recommending hospitalization of all teenagers. Study Objectives: (1) To determine the proportion of adolescents with PID who were admitted for failed outpatient treatment after the CDC guideline change. (2) To determine if adolescents admitted for PID after the guideline change needed longer hospital stays and/or were more likely to be "very ill" [as measured by inflammation markers, e.g. fever] or to have tubo-ovarian abscess (TOA) than those admitted before the change. Design: Retrospective chart review. Setting/Participants: All 12-21-year-old females with the diagnosis of PID admitted to an adolescent inpatient unit in an inner-city teaching hospital during a two-year period before [T1=1995-1997 (54 cases)] and after [T2=1998-2000 (91 cases)] the CDC guideline change. Interventions: None. Main Outcome measures: Reason for admission (failed outpatient treatment; TOA; or admission at the time of diagnosis of PID); clinical toxicity at admission, and length of hospital stay (LOS). Results: During T2, 22% of PID admissions were for failure of outpatient therapy. However, those admitted after failure of outpatient therapy (n=20) in T2 were less likely to be "very ill" than those who were admitted at the time of PID diagnosis in either T1 or T2 (n=123) [RR:0.30; 95% CI:0.09-0.94]. Mean LOS for females admitted to the adolescent unit with all diagnoses other than PID did not change between T1 and T2 but mean LOS for those diagnosed with PID decreased significantly from 6.3 ± 3.7 days to 4.7 ± 2.7 days, respectively (P = 0.002). LOS for PID was longer for younger (<16 years; 8.20 ± 4.5 days) than older (≥16 years; 5.0 ± 2.8 days) girls (P = 0.02) and for adolescents with TOA (7.9 ± 5.0 days) than for those without (5.3 ± 2.9 days) (P = 0.05). Conclusion: At our medical center, after the CDC guideline change many adolescents with PID were admitted because of failure of outpatient therapy but they were not sicker than those admitted at the time of diagnosis and overall LOS for PID was shorter. These findings are reassuring because they suggest that an initial trial of outpatient therapy for PID is unlikely to harm adolescents and may lead to significant cost savings.

UR - http://www.scopus.com/inward/record.url?scp=51349146488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349146488&partnerID=8YFLogxK

U2 - 10.1016/j.jpag.2008.07.014

DO - 10.1016/j.jpag.2008.07.014

M3 - Article

C2 - 18794025

AN - SCOPUS:51349146488

VL - 21

SP - 289

EP - 293

JO - Journal of Pediatric and Adolescent Gynecology

JF - Journal of Pediatric and Adolescent Gynecology

SN - 1083-3188

IS - 5

ER -